MetaVia (MTVA) Preferred Dividend Payments (2015 - 2017)

MetaVia's (MTVA) quarterly Preferred Dividend Payments came in at $0.63 in Q4 2017, down 23.17% on a QoQ basis from $0.82 in Q3 2017.

MetaVia (MTVA) Preferred Dividend Payments (2015 - 2017) Analysis & Trends

MetaVia (MTVA) has 3 years of Preferred Dividend Payments data on file, last reported at $0.63 in Q4 2017.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $0.63 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $3.23 (down 100.0% YoY) and the FY2017 annual result came in at $0.63, down 100.0% from the prior year.
Preferred Dividend Payments declined to $0.63 in Q4 2017, from $0.82 in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $2.5 million in Q1 2015 to a low of $0.63 in Q4 2017.
A 3-year average of $303091.2 and a median of $149000.0 in 2015 frame the typical range for Preferred Dividend Payments.
Annual changes were most pronounced in 2016 — Preferred Dividend Payments rose 0.67% — and 2017, when it sank 100.0%.
Tracing MTVA's Preferred Dividend Payments over 3 years: stood at $150000.0 in 2015, then tumbled by 55.33% to $67000.0 in 2016, then slumped by 100.0% to $0.63 in 2017.
The last three Preferred Dividend Payments figures came in at $0.63 (Q4 2017), $0.82 (Q3 2017), and $0.99 (Q2 2017), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	MetaVia	8.72 Mn	-3.92 Mn	-	-

Download Data